المؤلفون: Cho, Raymond, Kluk, MJ, Ashworth, T, Wang, H, Knoechel, B, Mason, EF, Morgan, EA, Dorfman, D, Pinkus, G, Weigert, O, Hornick, JL

URL الوصول: https://escholarship.org/uc/item/9gd6s4xr

المؤلفون: Allison DR; Division of Hematopathology, Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Dholaria B; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Kishtagari A; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Mohan S; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Steigelfest E; Division of Rheumatology and Immunology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Shaver AC; Division of Hematopathology, Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Mason EF; Division of Hematopathology, Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

المصدر: American journal of hematology [Am J Hematol] 2024 Jul; Vol. 99 (7), pp. 1400-1402. Date of Electronic Publication: 2024 Apr 06.

نوع المنشور: Case Reports; Letter

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Bone Marrow*/pathology , Ubiquitin-Activating Enzymes*/genetics, Humans ; Male ; Adult

المؤلفون: Fraebel J; Division of Hematology/Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA., Park S; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.; Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea., Shah R; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA., Prieto-Granada C; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, 37232, USA., Mason EF; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, 37232, USA., Sengsayadeth S; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.; Vanderbilt-Ingram Cancer Center (VICC), Nashville, TN, 37232, USA.; Veterans Affairs Medical Center, Tennessee Valley Healthcare System, Nashville, TN, 37232, USA., Chinratanalab W; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.; Vanderbilt-Ingram Cancer Center (VICC), Nashville, TN, 37232, USA.; Veterans Affairs Medical Center, Tennessee Valley Healthcare System, Nashville, TN, 37232, USA., Savani B; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.; Vanderbilt-Ingram Cancer Center (VICC), Nashville, TN, 37232, USA.; Veterans Affairs Medical Center, Tennessee Valley Healthcare System, Nashville, TN, 37232, USA., Jayani RV; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.; Vanderbilt-Ingram Cancer Center (VICC), Nashville, TN, 37232, USA., Kassim A; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.; Vanderbilt-Ingram Cancer Center (VICC), Nashville, TN, 37232, USA.; Veterans Affairs Medical Center, Tennessee Valley Healthcare System, Nashville, TN, 37232, USA., Dholaria BR; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.; Vanderbilt-Ingram Cancer Center (VICC), Nashville, TN, 37232, USA.; Veterans Affairs Medical Center, Tennessee Valley Healthcare System, Nashville, TN, 37232, USA., Kim TK; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA. tae.k.kim@vumc.org.; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, 37232, USA. tae.k.kim@vumc.org.; Vanderbilt-Ingram Cancer Center (VICC), Nashville, TN, 37232, USA. tae.k.kim@vumc.org.; Veterans Affairs Medical Center, Tennessee Valley Healthcare System, Nashville, TN, 37232, USA. tae.k.kim@vumc.org.

المصدر: Bone marrow transplantation [Bone Marrow Transplant] 2024 Jun; Vol. 59 (6), pp. 900-903. Date of Electronic Publication: 2024 Mar 11.

نوع المنشور: Case Reports; Letter; Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE

مواضيع طبية MeSH: Graft vs Host Disease*/etiology , Hematopoietic Stem Cell Transplantation*/adverse effects , Hematopoietic Stem Cell Transplantation*/methods, Humans ; Male ; Transplantation, Autologous ; Middle Aged ; Female

المؤلفون: Kim TK; Division of Hematology/Oncology, Department of Medicine.; Vanderbilt Center for Immunobiology, and.; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center.; Vanderbilt Ingram Cancer Center, Nashville, Tennessee, USA.; Section of Medical Oncology.; Section of Hematology, Department of Medicine, and., Han X; Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA.; Pelotonia Institute for Immuno-Oncology, OSUCCC-James Cancer Hospital.; Department of Microbial Infection and Immunity, The Ohio State University, Columbus, Ohio, USA., Hu Q; Division of Hematology/Oncology, Department of Medicine., Vandsemb EN; Department of Acute Medicine, Oslo University Hospital, Oslo, Norway., Fielder CM; Division of Hematology/Oncology, Department of Medicine., Hong J; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea., Kim KW; Division of Hematology/Oncology, Department of Medicine., Mason EF; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center., Plowman RS; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center., Wang J; Department of Pathology, New York University Grossman School of Medicine, New York, New York, USA., Wang Q; Key Laboratory of Digestive System Tumors of Gansu Province, Lanzhou University Second Hospital, Lanzhou, China., Zhang JP; Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA., Badri T; Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA., Sanmamed MF; Division of Immunology and Immunotherapy, CIMA, Universidad de Navarra, Pamplona, Spain., Zheng L; Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA.; Pelotonia Institute for Immuno-Oncology, OSUCCC-James Cancer Hospital., Zhang T; Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA., Alawa J; Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA., Lee SW; Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA., Zeidan AM; Section of Hematology, Department of Medicine, and., Halene S; Section of Hematology, Department of Medicine, and., Pillai MM; Section of Hematology, Department of Medicine, and., Chandhok NS; Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, Florida, USA., Lu J; Department of Genetics and., Xu ML; Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA., Gore SD; Section of Hematology, Department of Medicine, and.; National Cancer Institute, Cancer Therapy Evaluation Program, Investigational Drug Branch, Bethesda, Maryland, USA., Chen L; Section of Medical Oncology.; Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA.

المصدر: The Journal of clinical investigation [J Clin Invest] 2024 Feb 01; Vol. 134 (3). Date of Electronic Publication: 2024 Feb 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE

مواضيع طبية MeSH: Immune Evasion* , Leukemia, Myeloid, Acute*/drug therapy, Animals ; Humans ; Mice ; Bone Marrow ; Immunity, Cellular ; Immunotherapy

المؤلفون: Lovewell RR; NextCure Inc., Beltsville, Maryland, USA., Hong J; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Seoul National University Hospital and.; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea., Kundu S; NextCure Inc., Beltsville, Maryland, USA., Fielder CM; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Hu Q; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Kim KW; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Ramsey HE; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Gorska AE; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Fuller LS; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Tian L; NextCure Inc., Beltsville, Maryland, USA., Kothari P; NextCure Inc., Beltsville, Maryland, USA., Paucarmayta A; NextCure Inc., Beltsville, Maryland, USA., Mason EF; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center., Meza I; NextCure Inc., Beltsville, Maryland, USA., Manzanarez Y; NextCure Inc., Beltsville, Maryland, USA., Bosiacki J; NextCure Inc., Beltsville, Maryland, USA., Maloveste K; NextCure Inc., Beltsville, Maryland, USA., Mitchell N; NextCure Inc., Beltsville, Maryland, USA., Barbu EA; NextCure Inc., Beltsville, Maryland, USA., Morawski A; NextCure Inc., Beltsville, Maryland, USA., Maloveste S; NextCure Inc., Beltsville, Maryland, USA., Cusumano Z; NextCure Inc., Beltsville, Maryland, USA., Patel SJ; NextCure Inc., Beltsville, Maryland, USA., Savona MR; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Vanderbilt Center for Immunobiology.; Vanderbilt-Ingram Cancer Center, and.; Program in Cancer Biology, Vanderbilt University, Nashville, Tennessee, USA., Langermann S; NextCure Inc., Beltsville, Maryland, USA., Myint H; NextCure Inc., Beltsville, Maryland, USA., Flies DB; NextCure Inc., Beltsville, Maryland, USA., Kim TK; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center.; Vanderbilt Center for Immunobiology.; Vanderbilt-Ingram Cancer Center, and.; Program in Cancer Biology, Vanderbilt University, Nashville, Tennessee, USA.; Veterans Affairs Tennessee Valley Healthcare, Nashville, Tennessee, USA.

المصدر: The Journal of clinical investigation [J Clin Invest] 2023 Nov 15; Vol. 133 (22). Date of Electronic Publication: 2023 Nov 15.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/metabolism, Animals ; Humans ; Hematopoietic Stem Cells/metabolism ; Signal Transduction ; Disease Models, Animal ; Neoplastic Stem Cells/metabolism

المؤلفون: Batuello C; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, US., Mason EF; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, US.

المصدر: American journal of clinical pathology [Am J Clin Pathol] 2023 Sep 01; Vol. 160 (3), pp. 284-291.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 0370470 Publication Model: Print Cited Medium: Internet ISSN: 1943-7722 (Electronic) Linking ISSN: 00029173 NLM ISO Abbreviation: Am J Clin Pathol Subsets: MEDLINE

مواضيع طبية MeSH: Epstein-Barr Virus Infections*/diagnosis , Hodgkin Disease*/diagnosis , Lymphoma, Large B-Cell, Diffuse*/diagnosis , Lymphoma, Large B-Cell, Diffuse*/virology , Antigens, CD*/analysis, Humans ; Herpesvirus 4, Human ; Immunohistochemistry

المؤلفون: Moyo TK; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.; Levine Cancer Institute, Charlotte, North Carolina., Kishtagari A; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Villaume MT; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee., McMahon B; University of Colorado, Denver, Colorado., Mohan SR; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Stopczynski T; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.; Center for Quantitative Sciences, Vanderbilt University, Nashville, Tennessee., Chen SC; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.; Center for Quantitative Sciences, Vanderbilt University, Nashville, Tennessee., Fan R; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.; Center for Quantitative Sciences, Vanderbilt University, Nashville, Tennessee., Huo Y; Department of Electrical and Computer Engineering, Vanderbilt University School of Medicine, Nashville, Tennessee., Moon H; Department of Electrical and Computer Engineering, Vanderbilt University School of Medicine, Nashville, Tennessee., Tang Y; Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, Tennessee., Bejan CA; Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, Tennessee., Childress M; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee., Anderson I; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Rawling K; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Simons RM; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Moncrief A; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Caza R; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Dugger L; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Collins A; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Dudley CV; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Ferrell PB; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.; Program in Cancer Biology, Vanderbilt University School of Medicine, Nashville, Tennessee.; Center for Immunobiology, Vanderbilt University School of Medicine, Nashville, Tennessee., Byrne M; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Strickland SA; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Ayers GD; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.; Center for Quantitative Sciences, Vanderbilt University, Nashville, Tennessee., Landman BA; Department of Electrical and Computer Engineering, Vanderbilt University School of Medicine, Nashville, Tennessee.; Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, Tennessee., Mason EF; Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee., Mesa RA; Wake Forest Baptist Cancer Center, Winston-Salem, North Carolina., Palmer JM; Department of Internal Medicine, Mayo Clinic, Scottsdale, Arizona., Michaelis LC; Medical College of Wisconsin, Madison, Wisconsin., Savona MR; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.; Program in Cancer Biology, Vanderbilt University School of Medicine, Nashville, Tennessee.; Center for Immunobiology, Vanderbilt University School of Medicine, Nashville, Tennessee.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Jul 05; Vol. 29 (13), pp. 2375-2384.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Primary Myelofibrosis*/drug therapy , Primary Myelofibrosis*/metabolism , Janus Kinase Inhibitors*/therapeutic use, Humans ; Aged ; Phosphatidylinositol 3-Kinases ; Pyrimidines/therapeutic use ; Nitriles/therapeutic use

المؤلفون: Marvin-Peek J; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Mason EF; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee., Kishtagari A; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Jayani RV; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Dholaria B; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Kim TK; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee., Engelhardt BG; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Chen H; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee., Strickland S; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Savani B; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Ferrell B; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Kassim A; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Savona M; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Mohan S; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Byrne M; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee; Tennessee Oncology Midtown Center for Blood Cancers, Nashville, Tennessee. Electronic address: mbyrne@tnonc.com.

المصدر: Transplantation and cellular therapy [Transplant Cell Ther] 2023 Jun; Vol. 29 (6), pp. 390.e1-390.e10. Date of Electronic Publication: 2023 Mar 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/therapy , Hematopoietic Stem Cell Transplantation* , Myelodysplastic Syndromes*/genetics , Myelodysplastic Syndromes*/therapy , GATA2 Deficiency*, Adult ; Humans ; Retrospective Studies ; Mutation/genetics ; Tumor Suppressor Protein p53/genetics

المؤلفون: Ramia de Cap M; Harvard Medical School, Boston, MA, USA.; Beth Israel Deaconess Medical Center, Boston, MA, USA.; North Bristol NHS Trust, Bristol, UK., Wu LP; Harvard Medical School, Boston, MA, USA.; Beth Israel Deaconess Medical Center, Boston, MA, USA., Hirt C; Harvard Medical School, Boston, MA, USA.; Beth Israel Deaconess Medical Center, Boston, MA, USA., Pihan GA; Harvard Medical School, Boston, MA, USA.; Beth Israel Deaconess Medical Center, Boston, MA, USA., Patel SS; Weill Cornell Medical College, New York, NY, USA., Tam W; Weill Cornell Medical College, New York, NY, USA., Bueso-Ramos CE; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kanagal-Shamanna R; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Raess PW; Department of Pathology, Oregon Health & Science University, Portland, OR, USA., Siddon A; Yale School of Medicine, New Haven, CT, USA., Narayanan D; Harvard Medical School, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA., Morgan EA; Harvard Medical School, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA., Pinkus GS; Harvard Medical School, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA., Mason EF; Vanderbilt University Medical Center, Nashville, TN, USA., Hsi ED; Wake Forest Baptist Health, Winston-Salem, NC, USA., Rogers HJ; Cleveland Clinic, Cleveland, OH, USA., Toth L; Department of Pathology, The University of New Mexico, Albuquerque, NM, USA., Foucar K; Department of Pathology, The University of New Mexico, Albuquerque, NM, USA., Hurwitz SN; Department of Pathology, University of Pennsylvania, Philadelphia, PA, USA., Bagg A; Department of Pathology, University of Pennsylvania, Philadelphia, PA, USA., Rets A; ARUP Laboratories, Salt Lake City, UT, USA.; Department of Pathology, University of Utah, Salt Lake City, UT, USA., George TI; ARUP Laboratories, Salt Lake City, UT, USA.; Department of Pathology, University of Utah, Salt Lake City, UT, USA., Orazi A; Texas Tech University Health Sciences Center, Lubbock, TX, USA., Arber DA; Department of Pathology, University of Chicago, Chicago, IL, USA., Hasserjian RP; Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital, Boston, MA, USA., Weinberg OK; UT Southwestern Medical Center, Dallas, TX, USA.

مؤلفون مشاركون: Bone Marrow Pathology Group

المصدر: Leukemia & lymphoma [Leuk Lymphoma] 2023 May; Vol. 64 (5), pp. 972-980. Date of Electronic Publication: 2023 Mar 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

مواضيع طبية MeSH: Sarcoma, Myeloid*/diagnosis , Sarcoma, Myeloid*/genetics , Sarcoma, Myeloid*/pathology , Leukemia, Myeloid, Acute*/diagnosis , Leukemia, Myeloid, Acute*/genetics, Humans ; Bone Marrow/pathology ; Nuclear Proteins/genetics ; Nucleophosmin ; Retrospective Studies ; Cohort Studies ; Mutation ; Prognosis

المؤلفون: Cowfer BA; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Vanderbilt University Medical Center and Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, TN., Hunley TE; Division of Pediatric Nephrology, Department of Pediatrics, Vanderbilt University Medical Center and Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, TN., Mason EF; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN., Dulek DE; Division of Pediatric Infectious Disease, Department of Pediatrics, Vanderbilt University Medical Center and Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, TN., Benedetti DJ; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Vanderbilt University Medical Center and Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, TN.

المصدر: Journal of pediatric hematology/oncology [J Pediatr Hematol Oncol] 2023 Jan 01; Vol. 45 (1), pp. 38-40. Date of Electronic Publication: 2022 Sep 22.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9505928 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1536-3678 (Electronic) Linking ISSN: 10774114 NLM ISO Abbreviation: J Pediatr Hematol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Histoplasmosis*/complications , Histoplasmosis*/diagnosis , Histoplasmosis*/therapy , Down Syndrome*/complications , Thrombotic Microangiopathies*/etiology , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/complications, Female ; Humans ; Child ; Child, Preschool ; Amphotericin B/therapeutic use